Paper35201289
Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.
Sawada J and 7 others. Cancer Immunol Res, 2022. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival. Papers, record 35201289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35201289
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Tertiary Lymphoid Structures | Major topic |
| Female | |
| Humans | |
| Lymph Nodes | |
| Lymphocytes | |
| Venules |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA125255 | NCI NIH HHS | United States | R01CA125255 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 35362048 | Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression. | https://conductscience.org/library/papers/35362048 |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12819012 | Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. | Am J Pathol | 2003 | https://conductscience.org/library/papers/12819012 | PubMed |
| 2 | 22080953 | Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. | Nature | 2011 | https://conductscience.org/library/papers/22080953 | PubMed |
| 3 | 28404866 | Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/28404866 | PubMed |
| 4 | 20516212 | Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221. | Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20516212 | PubMed |
| 5 | 24523438 | Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24523438 | PubMed |
| 6 | 29887866 | Tetraspanin Assemblies in Virus Infection. | Front Immunol | 2018 | https://conductscience.org/library/papers/29887866 | PubMed |
| 7 | 28428953 | Tetraspanins Function as Regulators of Cellular Signaling. | Front Cell Dev Biol | 2017 | https://conductscience.org/library/papers/28428953 | PubMed |
| 8 | 15122201 | Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. | Nat Rev Immunol | 2004 | https://conductscience.org/library/papers/15122201 | PubMed |
| 9 | 28818916 | A pathology atlas of the human cancer transcriptome. | Science | 2017 | https://conductscience.org/library/papers/28818916 | PubMed |
| 10 | 25838376 | T cell exclusion, immune privilege, and the tumor microenvironment. | Science | 2015 | https://conductscience.org/library/papers/25838376 | PubMed |
| 11 | 31057546 | Comparative Transcriptomic Analysis Identifies a Range of Immunologically Related Functional Elaborations of Lymph Node Associated Lymphatic and Blood Endothelial Cells. | Front Immunol | 2019 | https://conductscience.org/library/papers/31057546 | PubMed |
| 12 | 31965091 | New predictors for immunotherapy responses sharpen our view of the tumour microenvironment. | Nature | 2020 | https://conductscience.org/library/papers/31965091 | PubMed |
| 13 | 24440720 | ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state. | Cell Rep | 2014 | https://conductscience.org/library/papers/24440720 | PubMed |
| 14 | 15494715 | Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. | Br J Cancer | 2004 | https://conductscience.org/library/papers/15494715 | PubMed |
| 15 | 18223200 | The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. | Development | 2008 | https://conductscience.org/library/papers/18223200 | PubMed |
| 16 | 26155419 | Understanding high endothelial venules: Lessons for cancer immunology. | Oncoimmunology | 2015 | https://conductscience.org/library/papers/26155419 | PubMed |
| 17 | 30865898 | Single-Cell Analysis Reveals Heterogeneity of High Endothelial Venules and Different Regulation of Genes Controlling Lymphocyte Entry to Lymph Nodes. | Cell Rep | 2019 | https://conductscience.org/library/papers/30865898 | PubMed |
| 18 | 31942075 | B cells and tertiary lymphoid structures promote immunotherapy response. | Nature | 2020 | https://conductscience.org/library/papers/31942075 | PubMed |
| 19 | 20947821 | Differential endothelial transcriptomics identifies semaphorin 3G as a vascular class 3 semaphorin. | Arterioscler Thromb Vasc Biol | 2011 | https://conductscience.org/library/papers/20947821 | PubMed |
| 20 | 1163637 | Studies on the structure and permeability of the microvasculature in normal rat lymph nodes. | Am J Pathol | 1975 | https://conductscience.org/library/papers/1163637 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42865890 | From TLS architecture to functional immune niches: division of labor among CAFs, HEVs, and antigen-presenting cells in cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42865890 | PubMed |
| 42749753 | Immunogenic cell death and tertiary lymphoid structures: bridging tumour cell death and immune organization. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/42749753 | PubMed |
| 42582929 | Mechanistic roles and clinical applications of tertiary lymphoid structures in colorectal cancer drug resistance. | Cancer Drug Resist | 2026 | https://conductscience.org/library/papers/42582929 | PubMed |
| 42563959 | MEOX2: a homeobox transcription factor with multifaceted biological functions and broad disease associations. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42563959 | PubMed |
| 42482188 | Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42482188 | PubMed |
| 42452880 | Tertiary lymphoid structures in gastrointestinal cancer: orchestrating tumour microenvironmental immune subcycles to elegantly amplify the cancer immunity cycle. | Ann Med | 2026 | https://conductscience.org/library/papers/42452880 | PubMed |
| 42400206 | High Endothelial Venules in Small Cell Lung Cancer: Prognostic Subtypes and Therapeutic Implications for Immunoradiotherapy. | Int J Cancer | 2026 | https://conductscience.org/library/papers/42400206 | PubMed |
| 42351178 | Tertiary lymphoid structures in breast cancer: Mechanistic insights, subtype-specific patterns, and therapeutic implications. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42351178 | PubMed |
| 42350046 | FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42350046 | PubMed |
| 42292349 | The life cycle of tertiary lymphoid structures in pancreatic cancer-a window of opportunity for immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292349 | PubMed |
| 42289752 | Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42289752 | PubMed |
| 42057826 | TSPAN32 as a biomarker associated with radiotherapy and immune microenvironment remodeling in lung adenocarcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42057826 | PubMed |
| 42028730 | Therapeutic potential of tertiary lymphoid structures in breast cancer (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42028730 | PubMed |
| 41653296 | Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse models. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/41653296 | PubMed |
| 41417033 | Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/41417033 | PubMed |
| 40897896 | Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity. | Nat Immunol | 2025 | https://conductscience.org/library/papers/40897896 | PubMed |
| 40511544 | Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/40511544 | PubMed |
| 40199901 | Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation. | Nat Commun | 2025 | https://conductscience.org/library/papers/40199901 | PubMed |
| 40104742 | Characterization of immune landscape and prognostic value of IL-17-related signature in invasive breast cancer. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40104742 | PubMed |
| 39744696 | B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. | Theranostics | 2025 | https://conductscience.org/library/papers/39744696 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35201289
GET https://conductscience.org/api/papers/v1/35201289/references?page=2